Quick10K

⚲

Wize Pharma

Filings

10-Q	2020-09-30	Filed 2020-11-16
10-Q	2020-06-30	Filed 2020-08-14
10-Q	2020-03-31	Filed 2020-05-15
10-K	2019-12-31	Filed 2020-03-30
10-Q	2019-09-30	Filed 2019-11-14
10-Q	2019-06-30	Filed 2019-08-14
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-01
S-1	2018-11-21	Public Filing
10-Q	2018-09-30	Filed 2018-11-13
10-Q	2018-06-30	Filed 2018-08-14
10-Q	2018-03-31	Filed 2018-05-15
S-1	2018-02-06	Public Filing
10-K	2017-12-31	Filed 2018-03-29
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-05-08
10-K	2016-12-31	Filed 2017-03-23
10-Q	2016-09-30	Filed 2016-11-16
10-Q	2016-06-30	Filed 2016-07-25
10-Q	2016-03-31	Filed 2016-05-09
10-K	2015-12-31	Filed 2016-03-02
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-12
10-Q	2015-03-31	Filed 2015-05-13
10-K	2014-12-31	Filed 2015-03-25
10-Q	2014-09-30	Filed 2014-11-13
10-Q	2014-06-30	Filed 2014-08-14
10-Q	2014-03-31	Filed 2014-05-08
10-K	2013-12-31	Filed 2014-03-27
10-Q	2013-09-30	Filed 2013-11-12
10-Q	2013-06-30	Filed 2013-08-02
10-Q	2013-03-31	Filed 2013-05-10
10-K	2012-12-31	Filed 2013-03-27
10-Q	2012-09-30	Filed 2012-11-14
10-Q	2012-06-30	Filed 2012-08-13
10-Q	2012-03-31	Filed 2012-05-15
10-K	2011-12-31	Filed 2012-03-30
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-19
10-Q	2011-03-31	Filed 2011-05-06
10-K	2010-12-31	Filed 2011-03-03
10-Q	2010-09-30	Filed 2010-11-04
10-Q	2010-06-30	Filed 2010-07-28
10-Q	2010-03-31	Filed 2010-05-07
10-K	2009-12-31	Filed 2010-03-16

Reports

8-K	2020-11-29
8-K	2020-07-08
8-K	2020-05-07
8-K	2020-03-08
8-K	2020-02-19
8-K	2020-01-09
8-K	2019-12-20
8-K	2019-12-09
8-K	2019-11-29
8-K	2019-09-11
8-K	2019-09-04
8-K	2019-05-31
8-K	2019-05-21
8-K	2019-05-02
8-K	2019-04-23
8-K	2019-03-04
8-K	2019-03-01
8-K	2019-02-24
8-K	2019-02-07
8-K	2019-01-04
8-K	2018-11-20
8-K	2018-11-07
8-K	2018-10-24
8-K	2018-10-22
8-K	2018-08-20
8-K	2018-08-15
8-K	2018-05-22
8-K	2018-05-07
8-K	2018-03-26
8-K	2018-03-26
8-K	2018-03-15
8-K	2018-03-01
8-K	2018-02-22
8-K	2018-02-20
8-K	2018-02-19
8-K	2018-02-15
8-K	2018-01-21
8-K	2018-01-08
8-K	2017-12-26

Wize Pharma Financials

WIZP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	0	3	2	2	1	530	1			0	0	150	56	9	5	9	14	42	6	26	15	13	6	18	11	215	591	427	99	3,183	2,442	1,795	1,485
Accounts Receivable	0
Inventory
PP&E						2	0	0	0	0	0	1	1	1	1	0	3	0	0							5	5	5	6	8	8	7	7
Assets	0	5	4	3	2	1,961	2	2	2	2	1	999	833	1,013	760	702	1,129	700	656	638	622	550	454	411	394	595	996	688	286	3,403	3,434	2,599	2,091
Accounts Payable	2									0																43	35	61	84	34	44	320	381
Long-Term Debt
Liabilities	90	2	4	1	1	993	1	1	2	2	2	2,058	2,213	2,703	2,932	3,200	3,513	3,981	4,135	4,280	4,501	4,710	4,818	5,001	5,156	3,693	3,338	2,955	2,482	250	2,193	2,134	2,238
Stockholders' Equity	-90	3	0	3	2	968	1	0	-0	-0	-1	-1,059	-1,380	-1,690	-2,172	-2,498	-2,384	-3,281	-3,479	-3,642	-3,879	-4,160	-4,364	-4,590	-4,762	-3,098	-2,342	-2,267	-2,196	212	1,241	465	-147


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue																												0	2			0	2
Cost of Revenue
Gross Profit
R&D			1	1	1	596	1	1	0	0	0	-144	-169	-212	-106	197	247	-1,362	85	43	30	41	1	8	2	439	210	89	222		63	158	230
SG&A			0	0	0	205	0	1	0	0	0	-23	-109	-133	-82	103	85	-843	44	64	185	139	83	133	126	689	326	1,180	738		528	981	609
Tax
Net Income			3	2	-2	-742	1	-9	-1	5	-0	174	292	361	207	-321	-353	2,358	-158	-137	-244	-377	-204	-226	-172	-2,364	-105	-868	515		148	-1,853	-872


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating			-1	-2	-2	-195	-0	-0	-0	-0	4		-94	-47	-4	4	8	-41	-36	20	-11	-2	-7	12	-7	-1,355	-504	-1,007	-364		-730	-468	-350
Cash Investing						-2	-0	1	0	0			0	0	0	0	-3	3	0	0	0	0					19	150	98		0	0	0
Cash Financing			0	-3	-3	0	0	0	0	0	0	0	0	0	0	0											861	196	-62		0	-150	0